SlideShare ist ein Scribd-Unternehmen logo
1 von 28
Downloaden Sie, um offline zu lesen
CONSIDERATIONSIN HUMAN SUBJECTS
RESEARCHFOR TEACHINGSCHOLARSHIP
Betsy Ripley
April 7, 2014
Federal Regulations and Policy stemming
from Belmont Principles
45 CFR 46 – DHHS Policy for Protection of Human
Research Subjects
21CFR50, 56, etc. – drugs, devices, biologics
Common Rule, DOD, DOE ……
ActivitiesrequiringIRBapproval
45 CFR 46.102(f)
RESEARCH
A systematic investigation designed to develop or
contribute to generalizable knowledge.
45 CFR 46.102(d)
AND
HUMAN SUBJECT
A living individual about whom an investigator conducting
research obtains
1) data through intervention or interaction with the
individual, or
2) identifiable private information
Quality Improvement
• OHRP FAQ’s http://answers.hhs.gov/ohrp/categories/1569
• To determine whether these regulations apply to a particular quality
improvement activity, the following questions should be addressed in
order:
• (1) does the activity involve research(45 CFR 46.102(d));
• (2) does the research activity involve human subjects (45 CFR 46.102(f));
• (3) does the human subjects research qualify for an exemption (45 CFR
46.101(b)); and
• (4) is the non-exempt human subjects research conducted or supported by
HHS or otherwise covered by an applicable FWA approved by OHRP.
QI as HSR
Goals
Purpose
Methods
Publication is not the main determinant
Is it Research??
A systematic investigation designed to develop or contribute to generalizable
knowledge.
Is this HSR?
• A weekly survey to determine work hours by all housestaff.
• A survey of housestaff regarding concentration, motor skill and sleep
patterns to be tied to work hours.
• Using “clickers” for a pre and post test as part of a TBL and obtaining
ward scores to correlate with knowledge as determined by pre and post
scores.
• Implementation of a discharge summary template to improve adequacy
of summary. Training half of the housestaff on the template and
providing it to the other half. Did the template and/or the training
improve the adequacy.
• Receiving a dataset with MCAT scores and board pass rates and
comparing by age, gender, and year of enrollment for past 5 years. Data
set contains age, gender, year of MCAT, MCAT score, year of board exam
and board score.
• Beginning a pilot project to train third year residents to teach fourth
year medical students how to convey bad news to a patient. The
program will involve role play, video, and writing. A survey will be
conducted with the residents, students and with the students again at
the end of their internship.
Document your decision!
• If you determine that it is not HSR then make a note to your
study file with an explanation of how you determined that.
• If you determine it is HSR then you will need to submit to the
IRB.
IRB ReviewContinuum
Exempt Expedited Full
Low Risk High
Level of potential risk determines
route of review
Minimal risk
The probability and magnitude of harm or
discomfort anticipated in the research are
not greater in and of themselves than those
ordinarily encountered in daily life or during
the performance of routine physical or
psychological examination or tests.
45 CFR 46.102(i) and 21 CFR 56.102(i)
“Risk Assessment”
Not just physical risks!
Consider:
- Emotional distress
- Embarrassment/ stigma
- Risk to financial status
- Risk to social status
- Risk to employment
- Risk to criminal/ civil
liability
- Invasion of privacy
- Etc.
Vulnerable Populations
• Children (less than 18 in VA)
• Pregnant women and neonates
• Prisoners
• Students
• Employees
• Trainees
• Adults with decisional challenges
Mechanisms for Initial IRB Review
•Exemption*
•Expedited Review
•Full Review (Convened)
*FDA requirements differ from the 45 CFR 46 and Common Rule
Exemption Categories:
45 CFR 46 101 (b)
1. *Typical educational practices
2. *Anonymous surveys, interviews, or
observation of public behavior (generally not
applicable to children)
3. Research with elected public officials,
appointed public officials, candidate for
public office)
4. *Existing data, documents, pathological
specimens, if publicly available or
unidentifiable (no identifiers retained)
5. Evaluation of public benefit service
programs
6. Taste and food quality evaluation and
consumer acceptance studies
Exempt [46.101(b)]
1. Research conducted in established or
commonly accepted educational
settings, involving normal educational
practices
Exempt [46.101(b)]
2. Survey, interviews or observations of public behavior,
unless
- information obtained is recorded in such a manner that
human subjects can be identified, directly or through
identifiers linked to the subjects; and
- any disclosure of the human subjects’ responses
outside the research could reasonably place the
subjects at risk of criminal or civil liability or be
damaging to the subjects’ financial standing,
employability, or reputation
Exempt [46.101(b)]
4. Research involving the collection or study
of existing data, if the data are publicly
available or if the information is recorded
by the investigator in such a manner that
subjects cannot be identified, directly or
through identifiers linked to the subjects
Categories for Expedited Review:
No greater than minimal risk!
Clinical studies: IND/IDE
NOT required
Blood sample collection
(routine methods –small
amounts)
Prospective collection of
biological samples—
noninvasive means
Data collected though
noninvasive means
(routinely practiced in
clinical settings)
Materials (data, documents,
specimens etc.) have been
collected or will be collected
for non-research purposes
Collection of voice, video or
digital data for research
purposes
Individual or group behavior,
surveys, interviews, oral
histories
Exempt<<< Review >>>Expedited
(1)
Minimal risk
One IRB or Qualified
Exempt reviewer
Fits one of 6 categories of
research
Usually no recorded
identifiers, with some
exception
Topic generally not
sensitive
Minimal risk research
One IRB reviewer outside of
convened meeting
Fits one of 7 expedited
categories (for initial review)
May include identifiers (direct
or indirect)
Topics not sensitive OR may
include some sensitive topics,
but confidentiality securely
protected
Exempt <<< Review >>>Expedited (2)
• Non-vulnerable
populations, with some
exception
• Exempt from formal
informed consent
requirement (but subjects
deserve to know about
the research if possible)
• Exempt from continuing
IRB review
• Populations may include
regulated vulnerable &
others with adequate
protections
• Required formal informed
consent process OR justify a
waiver of consent
• Requires IRB continuing
review at least annually
Full IRB Review
Does not qualify for exempt or expedited review
based on risk assessment by PI and/or IRB…….
Greater than minimal risk!
(some non-HSR requires IRB approval per regs)
2 reviewers present the study at a convened meeting
IRB majority finds all Criteria for Approval are
satisfied
Additional Review Requirements
• Type of Review Categories for Exempt and Expedited
• Documents: Surveys, Questionnaires, Ads
• Engagement of outside investigators or institutions
• GWAS criteria
• HIPAA
• COI as relates to human subjects
• Congruence of grants
• IRB office: CITI training, COI resolution, other review groups
(ex. investigational drug plan, biohazards)
8CriteriaforIRBApproval
45CFR46.111(a)
Select One or More IRB_Approval_Conditions
Filter by Number
Total Selected: 8 1-8 of 8
Number Long Name
1 Risks to subjects are minimized (i) by using procedures consistent with sound research
design and do not unnecessarily expose subjects to risk and (ii) if appropriate, by using
procedures already being performed for diagnostic or treatment purposes
2 Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects,
and the importance of the knowledge that may reasonably result
3 Selection of subjects is equitable
4 Informed consent will be sought from each prospective subject or the subject's LAR to
the extent required by 45 CFR 46.116 / 21 CFR 50.20
5 Informed consent will be appropriately documented in accordance with 45 CFR 46.117
/ 21 CFR 50.27
6 When appropriate, the research plan makes adequate provision for monitoring the data
collected to ensure the safety of subjects
7 The research plan includes adequate provisions to protect the privacy of subjects and
to maintain the confidentiality of data
8 When some or all of the subjects are likely to be vulnerable to coercion or undue
influence, additional safeguards have been included in the study to protect the rights
and welfare of these subjects.(46.111 (b))
Total Selected: 8 1-8 of 8
Duty to Report
• VCU Policy goes beyond traditional mandatory reporters
• Should be in your consent if appropriate
Consent
• Not formally required for Exempt
• Required for Full board or Expedited unless waived with required and if applicable
information
• Waiver of Consent: Waiver of some or all elements of informed consent/permission
may be appropriate:
- research is no greater than minimal risk
- no impact on rights or dignity of participants
- not practicable to obtain informed consent
- provide debrief after the research, as appropriate
• Waiver of Documentation of Consent
• Research presents no more than minimal risk*
• AND
• Research involves procedures that do not require written consent when performed
outside of a research setting
• Consent Templates on VCU IRB website
• RAMSIRB Consent Groups: This is the types of folks you will be consenting. For
instance if you are consenting medical residents for one survey, nursing staff for
another then that would be two groups.
Once Approved the Fun Starts
• Regulatory Binder
• Data Security
• Continuing Review
• Amendments
• Study Closure
• Prompt reports: Unanticipated Problems and SAEs
• Non prompt reports
RAMSIRB
• Main VCU IRB website
http://www.research.vcu.edu/human_research/conducting.htm
• RAMSIRB
• Must have VPN on computer if not at VCU/VCUHS
• Sign in with eid
• What you need to get started: CITI, FIR, PI CV, Consents,
Surveys, your plan.
• Student Trainee research
• Determine what type of research it is
Helpful hints to RAMSIRB
• Add editors
• Conversion Amendments
• Have to answer questions with *
• Help text
• You have to upload one document when you get to the personnel
screen. PI CV is usually it. This will then appear anytime a document is
requested. This is a running list of documents. Do not delete a
document unless you really want it gone from the system.
• Create a dummy study if want to see what happens with different
choices or know what you will be asked.
• Once submitted reviewer makes comments to you in the review section
on each page. If changes required before approval or need clarifications
they will send it back to you (electronically). You need to respond to
every reviewer comment even if to say OK or done or changes made.
Then submit again. Only those on the side with current access can work
on it. You can however look to see progress on the first screen
• If you have a question about a submitted study you can send a public
comment in the system.
HELP!
• Email or talk to me
• Send public comment in an already submitted protocol
• Other reviewers, IRB panel coordinators
• Michelle Stickler, Christine Davison, Susan Kimbrough
• ORSP@vcu.edu for questions about the content of the study
forms
• ERAHELP@vcu.edu for technical issues

Weitere ähnliche Inhalte

Was ist angesagt?

Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Serkan Kaçar
 
Feasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial NightmaresFeasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial Nightmaresjbarag
 
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...Professor Priscilla Harries
 
GW SEAS Academic Expectations
GW SEAS Academic ExpectationsGW SEAS Academic Expectations
GW SEAS Academic Expectationsseasgrad
 
Insight to Medicine Series IRB Talk 10.12.16
Insight to Medicine Series IRB Talk 10.12.16Insight to Medicine Series IRB Talk 10.12.16
Insight to Medicine Series IRB Talk 10.12.16Heather Park-May M.A
 
Informed consent process
Informed consent processInformed consent process
Informed consent processTímea Polgár
 
CassandraFoster_Resume 2016 v3
CassandraFoster_Resume 2016 v3CassandraFoster_Resume 2016 v3
CassandraFoster_Resume 2016 v3Cassandra Foster
 
Scientific misconduct by dr vijay kumar
Scientific misconduct by dr vijay kumarScientific misconduct by dr vijay kumar
Scientific misconduct by dr vijay kumarDr. Vijay Kumar
 
062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]Debra Johnson
 
Human Research Ethics Committee approval letter 030915
Human Research Ethics Committee approval letter 030915Human Research Ethics Committee approval letter 030915
Human Research Ethics Committee approval letter 030915Julie Lindsay
 
Scientific integrity
Scientific integrityScientific integrity
Scientific integrityscromartie123
 
scientific misconduct
scientific misconductscientific misconduct
scientific misconductkusuma latha
 
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Brook White, PMP
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,Malay Singh
 
INFORMED CONSENT: Pledge, Promise, Contract or Platitude? Key Aspects of Inf...
INFORMED CONSENT: Pledge, Promise, Contract or Platitude?  Key Aspects of Inf...INFORMED CONSENT: Pledge, Promise, Contract or Platitude?  Key Aspects of Inf...
INFORMED CONSENT: Pledge, Promise, Contract or Platitude? Key Aspects of Inf...Michael Swit
 
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...MedicReS
 
Research ethics in human experiment
Research   ethics  in  human experimentResearch   ethics  in  human experiment
Research ethics in human experimentSupriyaCS12
 
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...SOCRA CCRP Certification
 

Was ist angesagt? (20)

Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...
 
Approval proposal format of NHRC
Approval proposal format of NHRCApproval proposal format of NHRC
Approval proposal format of NHRC
 
Feasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial NightmaresFeasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial Nightmares
 
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...
Dr Beth Harris - NIHR Personal Research Training Awards for non-medical healt...
 
GW SEAS Academic Expectations
GW SEAS Academic ExpectationsGW SEAS Academic Expectations
GW SEAS Academic Expectations
 
Insight to Medicine Series IRB Talk 10.12.16
Insight to Medicine Series IRB Talk 10.12.16Insight to Medicine Series IRB Talk 10.12.16
Insight to Medicine Series IRB Talk 10.12.16
 
Informed consent process
Informed consent processInformed consent process
Informed consent process
 
CassandraFoster_Resume 2016 v3
CassandraFoster_Resume 2016 v3CassandraFoster_Resume 2016 v3
CassandraFoster_Resume 2016 v3
 
Scientific misconduct by dr vijay kumar
Scientific misconduct by dr vijay kumarScientific misconduct by dr vijay kumar
Scientific misconduct by dr vijay kumar
 
062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]
 
Human Research Ethics Committee approval letter 030915
Human Research Ethics Committee approval letter 030915Human Research Ethics Committee approval letter 030915
Human Research Ethics Committee approval letter 030915
 
Scientific integrity
Scientific integrityScientific integrity
Scientific integrity
 
scientific misconduct
scientific misconductscientific misconduct
scientific misconduct
 
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,
 
Irb
IrbIrb
Irb
 
INFORMED CONSENT: Pledge, Promise, Contract or Platitude? Key Aspects of Inf...
INFORMED CONSENT: Pledge, Promise, Contract or Platitude?  Key Aspects of Inf...INFORMED CONSENT: Pledge, Promise, Contract or Platitude?  Key Aspects of Inf...
INFORMED CONSENT: Pledge, Promise, Contract or Platitude? Key Aspects of Inf...
 
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...
FDA 2013 Clinical Investigator Training Course: Clinical Investigator Inspect...
 
Research ethics in human experiment
Research   ethics  in  human experimentResearch   ethics  in  human experiment
Research ethics in human experiment
 
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / ...
 

Ähnlich wie Human subjects and teaching scholarship

Ethical review process, mk sharma
Ethical review process, mk sharmaEthical review process, mk sharma
Ethical review process, mk sharmaSHARDA UNIVERSITY
 
Human Subject Protection in Clinical Research
Human Subject Protection in Clinical ResearchHuman Subject Protection in Clinical Research
Human Subject Protection in Clinical ResearchClinosolIndia
 
Ethics of clinical trials
Ethics of clinical trialsEthics of clinical trials
Ethics of clinical trialsSsuna Bashir
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsDRx Tejas Kanhed
 
Human Subjects, Research and Navigating the IRB Process
Human Subjects, Research and Navigating the IRB ProcessHuman Subjects, Research and Navigating the IRB Process
Human Subjects, Research and Navigating the IRB ProcessOSUCCC - James
 
Revised Common Rule and SBR 12.13.18
Revised Common Rule and SBR 12.13.18Revised Common Rule and SBR 12.13.18
Revised Common Rule and SBR 12.13.18MonicaAbakar
 
IRB Challenges QI vs Research
IRB Challenges   QI vs ResearchIRB Challenges   QI vs Research
IRB Challenges QI vs Researchmsschreiner
 
C wchildassent
C wchildassentC wchildassent
C wchildassentUIHSO
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring boardRamakanth Gadepalli
 
DATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxDATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxPartha70
 
IRB Longer Presentation Revised 10-3-16.pptx
IRB Longer Presentation Revised 10-3-16.pptxIRB Longer Presentation Revised 10-3-16.pptx
IRB Longer Presentation Revised 10-3-16.pptxSarahHuggins7
 
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdfnipuns1983
 
Institutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeInstitutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeChintamBaladattaSai
 
CORE: Ethics from an IRB Perspective
CORE: Ethics from an IRB PerspectiveCORE: Ethics from an IRB Perspective
CORE: Ethics from an IRB PerspectiveTrident University
 
Aim analytics panel: IRB
Aim analytics panel: IRBAim analytics panel: IRB
Aim analytics panel: IRBSungjin Nam
 

Ähnlich wie Human subjects and teaching scholarship (20)

Ethical review process, mk sharma
Ethical review process, mk sharmaEthical review process, mk sharma
Ethical review process, mk sharma
 
QI vs. Research 2.26.15 edits
QI vs. Research 2.26.15 editsQI vs. Research 2.26.15 edits
QI vs. Research 2.26.15 edits
 
Human Subject Protection in Clinical Research
Human Subject Protection in Clinical ResearchHuman Subject Protection in Clinical Research
Human Subject Protection in Clinical Research
 
Ethics of clinical trials
Ethics of clinical trialsEthics of clinical trials
Ethics of clinical trials
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
 
HPU IRB Presentation
HPU IRB PresentationHPU IRB Presentation
HPU IRB Presentation
 
58541541-GCP-GMP
58541541-GCP-GMP58541541-GCP-GMP
58541541-GCP-GMP
 
ct-2015-11-fowlerdixon
ct-2015-11-fowlerdixonct-2015-11-fowlerdixon
ct-2015-11-fowlerdixon
 
Human Subjects, Research and Navigating the IRB Process
Human Subjects, Research and Navigating the IRB ProcessHuman Subjects, Research and Navigating the IRB Process
Human Subjects, Research and Navigating the IRB Process
 
Revised Common Rule and SBR 12.13.18
Revised Common Rule and SBR 12.13.18Revised Common Rule and SBR 12.13.18
Revised Common Rule and SBR 12.13.18
 
Liza Dawson, "The Common Rule and Research with Data, Big and Small"
Liza Dawson, "The Common Rule and Research with Data, Big and Small"Liza Dawson, "The Common Rule and Research with Data, Big and Small"
Liza Dawson, "The Common Rule and Research with Data, Big and Small"
 
IRB Challenges QI vs Research
IRB Challenges   QI vs ResearchIRB Challenges   QI vs Research
IRB Challenges QI vs Research
 
C wchildassent
C wchildassentC wchildassent
C wchildassent
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring board
 
DATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxDATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptx
 
IRB Longer Presentation Revised 10-3-16.pptx
IRB Longer Presentation Revised 10-3-16.pptxIRB Longer Presentation Revised 10-3-16.pptx
IRB Longer Presentation Revised 10-3-16.pptx
 
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf
2a. The Institutional Review Boards (IRB) are entrusted to protect t.pdf
 
Institutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeInstitutional review board/Independent ethics Committee
Institutional review board/Independent ethics Committee
 
CORE: Ethics from an IRB Perspective
CORE: Ethics from an IRB PerspectiveCORE: Ethics from an IRB Perspective
CORE: Ethics from an IRB Perspective
 
Aim analytics panel: IRB
Aim analytics panel: IRBAim analytics panel: IRB
Aim analytics panel: IRB
 

Mehr von tjcarter

Class sessions 8 motivation and learning 3 28-19
Class sessions 8 motivation and learning 3 28-19Class sessions 8 motivation and learning 3 28-19
Class sessions 8 motivation and learning 3 28-19tjcarter
 
Class 7 mind, body, and spirit
Class 7 mind, body, and spiritClass 7 mind, body, and spirit
Class 7 mind, body, and spirittjcarter
 
Class session 6 march 14, 2019
Class session 6 march 14, 2019Class session 6 march 14, 2019
Class session 6 march 14, 2019tjcarter
 
Class 5 mezirow's tl theory adlt 671
Class 5   mezirow's tl theory adlt 671Class 5   mezirow's tl theory adlt 671
Class 5 mezirow's tl theory adlt 671tjcarter
 
Class session 4 sdl
Class session 4  sdlClass session 4  sdl
Class session 4 sdltjcarter
 
Class 4 knowles principles of andragogy rev
Class 4    knowles principles of andragogy revClass 4    knowles principles of andragogy rev
Class 4 knowles principles of andragogy revtjcarter
 
Class session 2 lindeman's era in the u.s.
Class session 2   lindeman's era in the u.s.Class session 2   lindeman's era in the u.s.
Class session 2 lindeman's era in the u.s.tjcarter
 
Class session 2 theoretical orientations a framework for the course
Class session 2 theoretical orientations   a framework for the courseClass session 2 theoretical orientations   a framework for the course
Class session 2 theoretical orientations a framework for the coursetjcarter
 
Class 2 or 3 houle's inquiring mind
Class 2 or 3 houle's inquiring mindClass 2 or 3 houle's inquiring mind
Class 2 or 3 houle's inquiring mindtjcarter
 
Class session 2 lindeman's era in the u.s.
Class session 2   lindeman's era in the u.s.Class session 2   lindeman's era in the u.s.
Class session 2 lindeman's era in the u.s.tjcarter
 
Class session 1 jan 31, 2019
Class session 1   jan 31, 2019Class session 1   jan 31, 2019
Class session 1 jan 31, 2019tjcarter
 
Class session 11 putting it all together
Class session 11   putting it all togetherClass session 11   putting it all together
Class session 11 putting it all togethertjcarter
 
Class session 11 putting it all together
Class session 11   putting it all togetherClass session 11   putting it all together
Class session 11 putting it all togethertjcarter
 
Developing an effective case study march 2018
Developing an effective case study march 2018Developing an effective case study march 2018
Developing an effective case study march 2018tjcarter
 
Class 5 planning a pogil
Class 5   planning a pogilClass 5   planning a pogil
Class 5 planning a pogiltjcarter
 
Class 1 intro spring 2018
Class 1 intro spring 2018Class 1 intro spring 2018
Class 1 intro spring 2018tjcarter
 
Session 11 significant learning
Session 11   significant learningSession 11   significant learning
Session 11 significant learningtjcarter
 
Writing mc qs for for tbls and pogils nov 5, 2017 class 8
Writing mc qs for  for tbls and pogils nov 5, 2017 class 8Writing mc qs for  for tbls and pogils nov 5, 2017 class 8
Writing mc qs for for tbls and pogils nov 5, 2017 class 8tjcarter
 
Kirkpatrick's evaluation model revised 2017
Kirkpatrick's evaluation model revised 2017Kirkpatrick's evaluation model revised 2017
Kirkpatrick's evaluation model revised 2017tjcarter
 
Class 7 intro to assessment rev for 2017
Class 7   intro to assessment rev for 2017Class 7   intro to assessment rev for 2017
Class 7 intro to assessment rev for 2017tjcarter
 

Mehr von tjcarter (20)

Class sessions 8 motivation and learning 3 28-19
Class sessions 8 motivation and learning 3 28-19Class sessions 8 motivation and learning 3 28-19
Class sessions 8 motivation and learning 3 28-19
 
Class 7 mind, body, and spirit
Class 7 mind, body, and spiritClass 7 mind, body, and spirit
Class 7 mind, body, and spirit
 
Class session 6 march 14, 2019
Class session 6 march 14, 2019Class session 6 march 14, 2019
Class session 6 march 14, 2019
 
Class 5 mezirow's tl theory adlt 671
Class 5   mezirow's tl theory adlt 671Class 5   mezirow's tl theory adlt 671
Class 5 mezirow's tl theory adlt 671
 
Class session 4 sdl
Class session 4  sdlClass session 4  sdl
Class session 4 sdl
 
Class 4 knowles principles of andragogy rev
Class 4    knowles principles of andragogy revClass 4    knowles principles of andragogy rev
Class 4 knowles principles of andragogy rev
 
Class session 2 lindeman's era in the u.s.
Class session 2   lindeman's era in the u.s.Class session 2   lindeman's era in the u.s.
Class session 2 lindeman's era in the u.s.
 
Class session 2 theoretical orientations a framework for the course
Class session 2 theoretical orientations   a framework for the courseClass session 2 theoretical orientations   a framework for the course
Class session 2 theoretical orientations a framework for the course
 
Class 2 or 3 houle's inquiring mind
Class 2 or 3 houle's inquiring mindClass 2 or 3 houle's inquiring mind
Class 2 or 3 houle's inquiring mind
 
Class session 2 lindeman's era in the u.s.
Class session 2   lindeman's era in the u.s.Class session 2   lindeman's era in the u.s.
Class session 2 lindeman's era in the u.s.
 
Class session 1 jan 31, 2019
Class session 1   jan 31, 2019Class session 1   jan 31, 2019
Class session 1 jan 31, 2019
 
Class session 11 putting it all together
Class session 11   putting it all togetherClass session 11   putting it all together
Class session 11 putting it all together
 
Class session 11 putting it all together
Class session 11   putting it all togetherClass session 11   putting it all together
Class session 11 putting it all together
 
Developing an effective case study march 2018
Developing an effective case study march 2018Developing an effective case study march 2018
Developing an effective case study march 2018
 
Class 5 planning a pogil
Class 5   planning a pogilClass 5   planning a pogil
Class 5 planning a pogil
 
Class 1 intro spring 2018
Class 1 intro spring 2018Class 1 intro spring 2018
Class 1 intro spring 2018
 
Session 11 significant learning
Session 11   significant learningSession 11   significant learning
Session 11 significant learning
 
Writing mc qs for for tbls and pogils nov 5, 2017 class 8
Writing mc qs for  for tbls and pogils nov 5, 2017 class 8Writing mc qs for  for tbls and pogils nov 5, 2017 class 8
Writing mc qs for for tbls and pogils nov 5, 2017 class 8
 
Kirkpatrick's evaluation model revised 2017
Kirkpatrick's evaluation model revised 2017Kirkpatrick's evaluation model revised 2017
Kirkpatrick's evaluation model revised 2017
 
Class 7 intro to assessment rev for 2017
Class 7   intro to assessment rev for 2017Class 7   intro to assessment rev for 2017
Class 7 intro to assessment rev for 2017
 

Human subjects and teaching scholarship

  • 1. CONSIDERATIONSIN HUMAN SUBJECTS RESEARCHFOR TEACHINGSCHOLARSHIP Betsy Ripley April 7, 2014
  • 2. Federal Regulations and Policy stemming from Belmont Principles 45 CFR 46 – DHHS Policy for Protection of Human Research Subjects 21CFR50, 56, etc. – drugs, devices, biologics Common Rule, DOD, DOE ……
  • 3. ActivitiesrequiringIRBapproval 45 CFR 46.102(f) RESEARCH A systematic investigation designed to develop or contribute to generalizable knowledge. 45 CFR 46.102(d) AND HUMAN SUBJECT A living individual about whom an investigator conducting research obtains 1) data through intervention or interaction with the individual, or 2) identifiable private information
  • 4. Quality Improvement • OHRP FAQ’s http://answers.hhs.gov/ohrp/categories/1569 • To determine whether these regulations apply to a particular quality improvement activity, the following questions should be addressed in order: • (1) does the activity involve research(45 CFR 46.102(d)); • (2) does the research activity involve human subjects (45 CFR 46.102(f)); • (3) does the human subjects research qualify for an exemption (45 CFR 46.101(b)); and • (4) is the non-exempt human subjects research conducted or supported by HHS or otherwise covered by an applicable FWA approved by OHRP.
  • 5. QI as HSR Goals Purpose Methods Publication is not the main determinant Is it Research?? A systematic investigation designed to develop or contribute to generalizable knowledge.
  • 6. Is this HSR? • A weekly survey to determine work hours by all housestaff. • A survey of housestaff regarding concentration, motor skill and sleep patterns to be tied to work hours. • Using “clickers” for a pre and post test as part of a TBL and obtaining ward scores to correlate with knowledge as determined by pre and post scores. • Implementation of a discharge summary template to improve adequacy of summary. Training half of the housestaff on the template and providing it to the other half. Did the template and/or the training improve the adequacy. • Receiving a dataset with MCAT scores and board pass rates and comparing by age, gender, and year of enrollment for past 5 years. Data set contains age, gender, year of MCAT, MCAT score, year of board exam and board score. • Beginning a pilot project to train third year residents to teach fourth year medical students how to convey bad news to a patient. The program will involve role play, video, and writing. A survey will be conducted with the residents, students and with the students again at the end of their internship.
  • 7. Document your decision! • If you determine that it is not HSR then make a note to your study file with an explanation of how you determined that. • If you determine it is HSR then you will need to submit to the IRB.
  • 8. IRB ReviewContinuum Exempt Expedited Full Low Risk High Level of potential risk determines route of review
  • 9. Minimal risk The probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examination or tests. 45 CFR 46.102(i) and 21 CFR 56.102(i)
  • 10. “Risk Assessment” Not just physical risks! Consider: - Emotional distress - Embarrassment/ stigma - Risk to financial status - Risk to social status - Risk to employment - Risk to criminal/ civil liability - Invasion of privacy - Etc.
  • 11. Vulnerable Populations • Children (less than 18 in VA) • Pregnant women and neonates • Prisoners • Students • Employees • Trainees • Adults with decisional challenges
  • 12. Mechanisms for Initial IRB Review •Exemption* •Expedited Review •Full Review (Convened) *FDA requirements differ from the 45 CFR 46 and Common Rule
  • 13. Exemption Categories: 45 CFR 46 101 (b) 1. *Typical educational practices 2. *Anonymous surveys, interviews, or observation of public behavior (generally not applicable to children) 3. Research with elected public officials, appointed public officials, candidate for public office) 4. *Existing data, documents, pathological specimens, if publicly available or unidentifiable (no identifiers retained) 5. Evaluation of public benefit service programs 6. Taste and food quality evaluation and consumer acceptance studies
  • 14. Exempt [46.101(b)] 1. Research conducted in established or commonly accepted educational settings, involving normal educational practices
  • 15. Exempt [46.101(b)] 2. Survey, interviews or observations of public behavior, unless - information obtained is recorded in such a manner that human subjects can be identified, directly or through identifiers linked to the subjects; and - any disclosure of the human subjects’ responses outside the research could reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, or reputation
  • 16. Exempt [46.101(b)] 4. Research involving the collection or study of existing data, if the data are publicly available or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects
  • 17. Categories for Expedited Review: No greater than minimal risk! Clinical studies: IND/IDE NOT required Blood sample collection (routine methods –small amounts) Prospective collection of biological samples— noninvasive means Data collected though noninvasive means (routinely practiced in clinical settings) Materials (data, documents, specimens etc.) have been collected or will be collected for non-research purposes Collection of voice, video or digital data for research purposes Individual or group behavior, surveys, interviews, oral histories
  • 18. Exempt<<< Review >>>Expedited (1) Minimal risk One IRB or Qualified Exempt reviewer Fits one of 6 categories of research Usually no recorded identifiers, with some exception Topic generally not sensitive Minimal risk research One IRB reviewer outside of convened meeting Fits one of 7 expedited categories (for initial review) May include identifiers (direct or indirect) Topics not sensitive OR may include some sensitive topics, but confidentiality securely protected
  • 19. Exempt <<< Review >>>Expedited (2) • Non-vulnerable populations, with some exception • Exempt from formal informed consent requirement (but subjects deserve to know about the research if possible) • Exempt from continuing IRB review • Populations may include regulated vulnerable & others with adequate protections • Required formal informed consent process OR justify a waiver of consent • Requires IRB continuing review at least annually
  • 20. Full IRB Review Does not qualify for exempt or expedited review based on risk assessment by PI and/or IRB……. Greater than minimal risk! (some non-HSR requires IRB approval per regs) 2 reviewers present the study at a convened meeting IRB majority finds all Criteria for Approval are satisfied
  • 21. Additional Review Requirements • Type of Review Categories for Exempt and Expedited • Documents: Surveys, Questionnaires, Ads • Engagement of outside investigators or institutions • GWAS criteria • HIPAA • COI as relates to human subjects • Congruence of grants • IRB office: CITI training, COI resolution, other review groups (ex. investigational drug plan, biohazards)
  • 22. 8CriteriaforIRBApproval 45CFR46.111(a) Select One or More IRB_Approval_Conditions Filter by Number Total Selected: 8 1-8 of 8 Number Long Name 1 Risks to subjects are minimized (i) by using procedures consistent with sound research design and do not unnecessarily expose subjects to risk and (ii) if appropriate, by using procedures already being performed for diagnostic or treatment purposes 2 Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably result 3 Selection of subjects is equitable 4 Informed consent will be sought from each prospective subject or the subject's LAR to the extent required by 45 CFR 46.116 / 21 CFR 50.20 5 Informed consent will be appropriately documented in accordance with 45 CFR 46.117 / 21 CFR 50.27 6 When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects 7 The research plan includes adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data 8 When some or all of the subjects are likely to be vulnerable to coercion or undue influence, additional safeguards have been included in the study to protect the rights and welfare of these subjects.(46.111 (b)) Total Selected: 8 1-8 of 8
  • 23. Duty to Report • VCU Policy goes beyond traditional mandatory reporters • Should be in your consent if appropriate
  • 24. Consent • Not formally required for Exempt • Required for Full board or Expedited unless waived with required and if applicable information • Waiver of Consent: Waiver of some or all elements of informed consent/permission may be appropriate: - research is no greater than minimal risk - no impact on rights or dignity of participants - not practicable to obtain informed consent - provide debrief after the research, as appropriate • Waiver of Documentation of Consent • Research presents no more than minimal risk* • AND • Research involves procedures that do not require written consent when performed outside of a research setting • Consent Templates on VCU IRB website • RAMSIRB Consent Groups: This is the types of folks you will be consenting. For instance if you are consenting medical residents for one survey, nursing staff for another then that would be two groups.
  • 25. Once Approved the Fun Starts • Regulatory Binder • Data Security • Continuing Review • Amendments • Study Closure • Prompt reports: Unanticipated Problems and SAEs • Non prompt reports
  • 26. RAMSIRB • Main VCU IRB website http://www.research.vcu.edu/human_research/conducting.htm • RAMSIRB • Must have VPN on computer if not at VCU/VCUHS • Sign in with eid • What you need to get started: CITI, FIR, PI CV, Consents, Surveys, your plan. • Student Trainee research • Determine what type of research it is
  • 27. Helpful hints to RAMSIRB • Add editors • Conversion Amendments • Have to answer questions with * • Help text • You have to upload one document when you get to the personnel screen. PI CV is usually it. This will then appear anytime a document is requested. This is a running list of documents. Do not delete a document unless you really want it gone from the system. • Create a dummy study if want to see what happens with different choices or know what you will be asked. • Once submitted reviewer makes comments to you in the review section on each page. If changes required before approval or need clarifications they will send it back to you (electronically). You need to respond to every reviewer comment even if to say OK or done or changes made. Then submit again. Only those on the side with current access can work on it. You can however look to see progress on the first screen • If you have a question about a submitted study you can send a public comment in the system.
  • 28. HELP! • Email or talk to me • Send public comment in an already submitted protocol • Other reviewers, IRB panel coordinators • Michelle Stickler, Christine Davison, Susan Kimbrough • ORSP@vcu.edu for questions about the content of the study forms • ERAHELP@vcu.edu for technical issues